Chemomab Therapeutics Ltd.

Pharmaceutical company · Tel Aviv, Israel · Nasdaq: CMMB

Chemomab Therapeutics Ltd. is a pharmaceutical company headquartered in Tel Aviv, Israel. Its shares trade on Nasdaq under the ticker CMMB. It has reported private securities offerings to the US SEC, most recently $10 million sold in a notice filed in 2024.

Profile compiled from public records. Is this your company? Request a correction or update

Chemomab Therapeutics at a glance

Typepharmaceutical company

HeadquartersTel Aviv, Israel

Stock listingNasdaq: CMMB

SEC industryPharmaceutical Preparations

SEC CIK1534248

What does Chemomab Therapeutics do?

Private fundraising reported to the SEC

2 Form D notices; the most recent reported $10 million sold (2024).

Frequently asked questions about Chemomab Therapeutics

Where is Chemomab Therapeutics headquartered?

Chemomab Therapeutics Ltd. is headquartered in Tel Aviv, Israel.

What does Chemomab Therapeutics do?

Chemomab Therapeutics Ltd. is a pharmaceutical company. Its SEC industry classification is Pharmaceutical Preparations.

Is Chemomab Therapeutics a public company?

Yes. Chemomab Therapeutics Ltd. trades on Nasdaq under the ticker CMMB.

Similar companies

RedHill Biopharma Ltd.Tel Aviv, Israel
Nasus Pharma LtdTel Aviv, Israel
UroGen Pharma Ltd.Ra'anana, Central District, Israel
MediWound Ltd.Yavné, Central District, Israel
Can-Fite BioPharma Ltd.Ramat Gan, Tel Aviv, Israel
NeuroSense Therapeutics Ltd.Herzliya, Tel Aviv, Israel
BioLineRx Ltd.Modi‘in Makkabbim Re‘ut, Central District, Israel

Need a CRO or CDMO for your next study?

Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.

Compare quotes

Sources

Location data: GeoNames (geonames.org), CC BY 4.0.

Last updated 2026-09-23.